Acoustic pattern recognition and orientation in orthopteran insects: parallel or serial processing?

D. Helversen,O. V. Helversen

DOI: https://doi.org/10.1007/BF00187635

1995-12-01

Journal of Comparative Physiology

Abstract:

What problem does this paper attempt to address?

Determination of Diphenytriazol (DL111-IT) in Rabbit Plasma by High-Performance Liquid Chromatography with Fluorescence Detection

Min HE,Tong-wei YAO

2005-01-01

Journal of Chinese Pharmaceutical Sciences

Abstract:Aim To develop an HPLC method with fluorescence detection for the assay of DL111-IT in rabbit plasma. Methods DL111-IT and internal standard glybenzcyclamide in rabbit plasma were extracted with chloroform. The determination was performed on a Diamonsil ODS-C18 column (150 mm×4.6 mm, 5 μm) with a mobile phase of acetonitrile and 0.025 mol·L-1 diammonium hydrogen phosphate buffer (pH 5.0, adjusted by phosphoric acid) (60∶40, V/V) at a flow-rate of 1.0 mL·min-1. Fluorescence detector was operated at excitation wavelength of 250 nm and emission wavelength of 332 nm. Results The calibration curve in plasma was linear from 1.00-20.00 ng·mL-1(r=0.999 6, n=5). The method afforded average extracting recoveries of 85.3%±1.3%, 84.9%±2.7% and 85.8%±1.8%, and the average method recoveries were 99.5%±0.4%, 102.1%±1.8% and 101.3%±2.4% for the high (20.00 ng·mL-1), middle (10.00 ng·mL-1) and low (1.00 ng·mL-1) check samples, respectively. The intra-day (n=5) and inter-day (n=5) precisions (RSD) were less than 3.0% and 7.0%, respectively. The limit of detection and quantitation for the method were 0.3 ng·mL-1(S/N=3) and 1 ng·mL-1(S/N=10, RSD<7.0%) plasma sample, respectively. Conclusion The developed method was accurate, sensitive, simple and could be used for pharmacokinetic study of DL111-IT.
Quantification of Teicoplanin in Human Plasma by Liquid Chromatography with Ultraviolet Detection

Jie Shen,Zheng Jiao,Yinan Zhou,Huili Zhu,Zhongjuan Song

DOI: https://doi.org/10.1365/s10337-006-0115-4

2006-01-01

Chromatographia

Abstract:A simple high-performance liquid chromatographic method was developed for determining five major components of teicoplanin, designated A2–1, A2–2, A2–3, A2–4 and A2–5, in human plasma. Using piperacillin sodium as internal standard, teicoplanin in plasma samples was extracted by coextractive cleanup procedure. The extracts were injected into a Nova-Pak C18 column maintained at ambient temperature. The mobile phase consisted of acetonitrile–0.1% trifluoroacetic acid (27:73, pH = 2.2), at a flow rate of 1.0 mL min−1. The analytes were detected at the UV wavelength of 218 nm. The method was found to be linear over the concentration range of 2.5–50 mg L−1 for teicoplanin (r = 0.9993 ± 0.0038), which covered the clinically expected trough plasma levels. The percentage error of the analytical method was below 9%. The intra- and inter-day reproducibility was adequate with coefficients of variation less than 7%. The chromatographic running time was 11 min. Thus, the method can be effectively applied to measure teicoplanin concentrations in clinical samples.
Design and strategy for spectrofluorimetric determination of tranexamic acid in its authentic form and pharmaceutical preparations: application to spiked human plasma

Ebtehal F Anwer,Deena A M Nour El-Deen,Mahmoud A Omar

DOI: https://doi.org/10.1002/bio.4068

IF: 2.613

Luminescence

Abstract:A creative, very sensitive and noncomplicated spectrofluorimetric technique was established and further validated to determine tranexamic acid in both its authentic form and its pharmaceutical preparation dosage forms. In the introduced technique, a reaction was found between the aliphatic primary amino group of tranexamic acid and ninhydrin/phenylacetaldehyde reagents in the presence of Torell and Steinhagen buffer pH 7.0, which led to the production of a highly fluorescent product; fluorescence intensity was measured at 475 nm after excitation at 391 nm. A calibration curve was drawn with a linear range of 0.3-2 μg/ml. Limit of detection and limit of quantification values were 0.051 and 0.155 μg/ml respectively. The introduced technique was validated based on the International Council for Harmonisation guidelines and agreed for determination of tranexamic acid in its pharmaceutical formulation. Finally, this simple method was also applied for determination of tranexamic acid in spiked human plasma.
Analysis using fluorescence polarization immunoassay for unbound teicoplanin concentration in serum

T Urakami,T Maiguma,H Kaji,S Kondo,D Teshima

DOI: https://doi.org/10.1111/j.1365-2710.2008.00923.x

Abstract:Objectives: The aim of this study was to develop a simpler and more rapid analytical method for unbound teicoplanin in serum. Methods: A new analytical method was developed by modifying an existing fluorescence polarization immunoassay (FPIA) method. The validation of the developed FPIA method was compared in the quantification of unbound teicoplanin with that of the high-performance liquid chromatography (HPLC) method reported previously. The developed FPIA method was employed for the measurement of 36 clinical samples collected from patients with methicillin-resistant Staphylococcus aureus (MRSA) infection. Results: The limits of detection and quantification were 0.5 and 0.8 mug/mL, respectively. The recovery rate was 97.5-106.6%. The developed FPIA method showed better accuracy than the HPLC method. The within-run and interday reproducibility of the assay was good, with relative standard deviation values of 4.76-18.75% (within-run) and 5.68-13.95% (interday). Precision and accuracy of this method were within the acceptable limits defined in the US FDA Guidance for bioanalytical method validation. The correlation between the developed FPIA method and the HPLC method was good (r(2) = 0.87). A positive bias with the FPIA method was observed from the result of the Bland-Altman difference plot. Conclusion: We firmly believe that the present method is useful for the adjustment of teicoplanin dosages for patients under various conditions.
Simultaneous quantification of linezolid, tinidazole, norfloxacin, moxifloxacin, levofloxacin, and gatifloxacin in human plasma for therapeutic drug monitoring and pharmacokinetic studies in human volunteers

Sally A Helmy

DOI: https://doi.org/10.1097/FTD.0b013e318297b6b0

Abstract:Background: Linezolid may be administered in combination with norfloxacin, gatifloxacin, levofloxacin, moxifloxacin, and tinidazole for the treatment of various infections, such as urinary and respiratory tract infections, to improve the efficacy of the treatment or to reduce the duration of therapy. Knowledge of the antibiotic plasma concentrations combined with bacterial susceptibility evaluated in terms of minimum inhibitory concentration would optimize treatment efficacy while limiting the risk of dose-related adverse effects and avoiding suboptimal concentrations. Methods: A new high-performance liquid chromatography assay method was developed and validated for determination of the above-mentioned drugs in small samples of human plasma. After protein precipitation with acetonitrile:methanol (1:1, vol/vol), satisfactory separation was achieved on a Hypersil BDS C18 column (250 × 4.6 mm, 5 μm) using a mobile phase comprising 20 mM sodium dihydrogen phosphate-2 hydrate (pH = 3.2) and acetonitrile at a ratio of 75:25, vol/vol; the elution was isocratic at ambient temperature with a flow rate of 1.5 mL/min. The ultraviolet detector was set at 260 nm. The validated method was applied to assay real plasma samples used for pharmacokinetic studies and therapeutic drug monitoring of the selected drugs. Results: The assay method described was found to be rapid, sensitive, reproducible, precise, and accurate. Linearity was demonstrated over the concentration ranges as follows: 0.1-30 μg/mL for linezolid and tinidazole; 0.05-5 μg/mL for norfloxacin; and 0.1-10 μg/mL for moxifloxacin, levofloxacin, and gatifloxacin (mean r = 0.9999, n = 12). The observed within- and between-day assay precisions were within 12.5%, whereas accuracy ranged between 92.0% and 112% for all the analytes. The lower limit of quantification was 0.1 μg/mL for all the analytes except norfloxacin which was 0.05 μg/mL. Conclusions: This assay method was valid within a wide range of plasma concentrations and may be proposed as a suitable method for pharmacokinetic studies, therapeutic drug monitoring implementation, and routine clinical applications, especially for some populations of patients who receive a combination of these drugs.
Development and validation of a sensitive liquid chromatography-tandem mass spectrometry method for the determination of naringin and its metabolite, naringenin, in human plasma.

Xin Xiong,Junjie Jiang,Jingli Duan,Yanming Xie,Jiannong Wang,Suodi Zhai

DOI: https://doi.org/10.1093/chromsci/bmt095

2014-01-01

Journal of Chromatographic Science

Abstract:A sensitive and specific method was developed for the simultaneous determination of naringin and its metabolite, naringenin, in human plasma by liquid chromatography-tandem mass spectrometry. Hesperidin was used as the internal standard, plasma samples were extracted with ethyl acetate and the analytes were chromatographically separated by using acetonitrile-0.1% formic acid (gradient elution) as the mobile phase. Detection was performed by electrospray ionization mass spectrometry in negative ion mode with multiple reaction monitoring. The lower limit of quantification was 0.5 ng/mL for naringin and naringenin and the linear calibration curves ranged from 0.5 to 200 ng/mL. The intra-run and inter-run precision values were within 8.6 and 7.7% for naringin and between 13.1 and 10.3% for naringenin. The accuracy ranged from 91.3 to 98.2% for naringin and from 90.2 to 97.6 % for naringenin. The validated method was successfully applied to determine concentrations of naringin and naringenin in clinical patients.
Spectrofluorimetric determination of Alogliptin benzoate through condensation with ninhydrin and phenylacetaldehyde: application to dosage form and rat plasma

DOI: https://doi.org/10.1007/s11696-024-03451-0

IF: 2.146

2024-05-02

Chemical Papers

Abstract:Alogliptin benzoate (ALG) is a dipeptidyl peptidase-4 inhibitor used to treat type 2 diabetes mellitus. In this study, a spectrofluorimetric method was developed for the derivatization of ALG to develop a fluorescent derivative. The derivatization reaction was carried out by reacting ALG with ninhydrin and phenylacetaldehyde in Teorell and Stenhagen buffer at pH 6.6. The reaction product was a fluorescent pyrrolidone derivative that was observed at őĽ ex of 385¬†nm and őĽ em of 475¬†nm. The effects of various experimental conditions on the derivatization reaction were investigated. The optimal conditions were found to be a reaction time of 15¬†min, a temperature of 80¬†¬įC, and a concentration of ninhydrin and phenylacetaldehyde of 1.4¬†mg¬†mL ‚ąí1 and 0.028% v/v, respectively. A calibration plot was constructed in the concentration range of 20‚Äď460¬†ng¬†mL ‚ąí1 . The calibration curve had a high correlation coefficient of 0.9991 and a low detection limit of 6.57¬†ng¬†mL ‚ąí1 . The eco-scale penalty points for the derivatization method were calculated to be 86. This indicates that the method is environmentally friendly and has a low risk of generating harmful waste. The derivatization method described in this study provides a sensitive and green method for the quantification of ALG in pure form, dosage form, spiked and real rat plasma.

chemistry, multidisciplinary
Application of the green analytical procedure index to the simultaneous analysis of co-formulated tinidazole and ciprofloxacin in pure form, tablet dosage form, and human plasma using an environmentally friendly micellar high-performance thin-layer chromatographic technology

DOI: https://doi.org/10.1007/s00764-023-00225-4

2023-02-13

Abstract:In individuals with chronic refractory pouchitis and other gastrointestinal disorders, the combination of ciprofloxacin (CIP) and tinidazole (TIN) is beneficial and safe. As a result, a green micellar high-performance thin-layer chromatographic (HPTLC) approach for the immediate analysis of TIN and CIP in pure, spiked human plasma, and co-formulated tablet dosage form has been developed. It is rapid, extremely easy, sensitive, cost-effective, and environmentally friendly. The stationary phase was Merck aluminum HPTLC plates covered with silica gel 60 F 254 , while the mobile phase was acetone–ethanol–2% watery sodium dodecyl sulfate (3:4:2, V/V ). For quantification of both medications, the densitometric scanner was set at 310 nm. For TIN and CIP, this chromatographic separation yielded symmetric, compact peaks with R F values of (0.22 ± 0.009) and (0.42 ± 0.007), respectively. At 310 nm, the separated spots were densitometrically scanned. For TIN and CIP, the detection thresholds were 6.7 ng/band and 25.03 ng/band, respectively. For TIN and CIP, the quantification limits were 20.3 ng/band and 75.25 ng/band, respectively. The approach was validated according to International Council for Harmonisation (ICH) principles and then used to determine the researched medicines in their various pharmaceutical dosage forms, and human plasma yielding an exceptional percent of recovery. In terms of precision and accuracy, the results were in great accordance with the published approach. This method is suitable for the sequential analysis of the two drugs in pure form, tablet dosage forms, and spiked human plasma due to its simplicity, speed, greenness, robustness, and low cost.

chemistry, analytical
An Analytical Method Built for Irinotecan and Its Active Metabolite SN-38 in Human Plasma Using HPLC-FLD

SHAO Teng-fei,ZHENG Yuan-ting,XU Jia-lin,CAI Wei-min

DOI: https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2012.01.020

2012-01-01

Abstract:OBJECTIVE To develop and validate a method for simultaneous determination of irinotecan(CPT-11) and its metabolite SN-38 in human plasma by HPLC-FLD. METHODS Chromatographic separation was performed on a Luna 5u CN 100A column(4.6 mm×150 mm,5 μm),using acetonitrile: ammonium acetate(50 mmol·L-1,pH=4) as mobile phase.The detection wavelength of CPT-11 was Ex/Em=368 nm/432 nm,and the detection wavelength of SN-38 was Ex/Em=368 nm/535 nm. RESULTS The retention time of CPT-11 and SN-38 was(9.3±0.3)min and(4.8±0.3)min,respectively.No interfering peaks were observed at the retention time of both targets and interna standards.The assay was linear at the range 46.9-6 000.0 nmol·L-1 for CPT-11(r=0.998) and 2.0-250.0 nmol· L-1 for SN-38(r=0.998).Both the inter-and intra-batch precisions were less than 20% at the low concentration and less than 15% at the middle and high concentrations.The inter-and intra-accuracies were all between 85% and 115%.The spiked plasma samples were stable at-20 ℃ in a long-term stability test.After three freeze-thaw cycles of the spiked samples,the changes in levels of SN-38 and CPT-11 were both within 15%.The changes in levels of SN-38 and CPT-11 in 24 h after extraction were not obvious. CONCLUSION HPLC-FLD method for detection of concentrations of irinotecan(CPT-11) and its active metabolites SN-38 in human plasma is simple,accurate and sensitive.
Utility of Experimental Design in Pre-Column Derivatization for the Analysis of Tobramycin by HPLC—Fluorescence Detection: Application to Ophthalmic Solution and Human Plasma

Asmaa A. El-Zaher,Marianne A. Mahrouse

DOI: https://doi.org/10.4137/aci.s11612

2013-01-01

Analytical Chemistry Insights

Abstract:A novel, selective, and sensitive reversed phase high-performance liquid chromatography (HPLC) method coupled with fluorescence detection has been developed for the determination of tobramycin (TOB) in pure form, in ophthalmic solution and in spiked human plasma. Since TOB lacks UV absorbing chromophores and native fluorescence, pre -column derivatization of TOB was carried out using fluorescamine reagent (0.01%, 1.5 mL) and borate buffer (pH 8.5, 2 mL). Experimental design was applied for optimization of the derivatization step. The resulting highly fluorescent stable derivative was chromatographed on C 18 column and eluted using methanol:water (60:40, v/v) at a flow rate of 1 mL min −1 . A fluorescence detector (λ ex 390 and λ em 480 nm) was used. The method was linear over the concentration range 20-200 ng mL −1 . The structure of the fluorescent product was proposed, the method was then validated and applied for the determination of TOB in human plasma. The results were statistically compared with the reference method, revealing no significant difference.

English Else
A probe of new molecularly imprinted solid-phase extraction coupled with HPLC-DAD and atomic absorption spectrophotometry for quantification of tetracycline HCl, metronidazole and bismuth subcitrate in combination with their official impurities: Application in dosage form and human plasma

Amal M Hassan,Khadiga M Kelani,Maha A Hegazy,Ahmed H Nadim,Mahmoud A Tantawy

DOI: https://doi.org/10.1016/j.jchromb.2024.124032

2024-02-15

Abstract:The integration of molecular imprinting technique with chromatographic one has a great impact on the assay's selectivity and sensitivity. Herein, a molecularly imprinted solid-phase extraction associated with high performance liquid chromatography (MISPE-HPLC) was employed for simultaneous determination of the co-formulated drugs; tetracycline hydrochloride (TET) and metronidazole (MET), in plasma and in their anti-H-pylori drug for the first time. Two sorts of molecularly imprinted polymers (MIPs) were fabricated using TET and MET as the template molecules, while ethylene glycol dimethacrylate and methacrylic acid were used as a cross-linker and a monomer, respectively. The synthesized MIPs were identified using different techniques. The adsorption-desorption capability of each template was investigated towards its corresponding MIP. The extraction conditions of MISPE was optimized with respect to TET/MIP and MET/MIP sorbent. Bismuth subcitrate (BSC), the third co-formulated drug was analyzed in spiked human plasma using an atomic absorption spectrometric (AAS) method. The performance of the developed methods was assured as per ICH guidelines for analyzing the studied drugs in their pharmaceutical dosage form along with two of their official impurities. In addition, bioanalytical method validation was conducted where linearity was achieved at 2.0-40.0 μg mL-1, 2.0-40.0 μg mL-1 and 5.0-80.0 μg mL-1 for TET, MET and BSC, respectively.
Mechanisms of inactivation of deoxyribonucleic acids by heat.

W. Ginoza,B. Zimm

DOI: https://doi.org/10.1073/PNAS.47.5.639

1961-05-15

Abstract:of
Development and Validation of a High-Performance Liquid Chromatography-Ultraviolet Spectrometry Method for Ampicillin and its Application in Routine Therapeutic Drug Monitoring of Intensive Care Patients

Benedict Morath,Linda Schultes,Otto Roman Frey,Anka Christa Röhr,Hannes Christow,Torsten Hoppe-Tichy,Alexander Brinkmann,Ute Chiriac

DOI: https://doi.org/10.1097/FTD.0000000000001253

2024-09-18

Abstract:Background: Ampicillin/sulbactam, a combination of a β-lactam and β-lactamase inhibitor, is widely used in clinical settings. However, therapeutic drug monitoring (TDM) of ampicillin is not commonly performed, particularly in intensive care units (ICUs). The purpose of this study was to develop and validate a rapid and cost-effective high-performance liquid chromatography (HPLC)-ultraviolet spectrometry method to quantify ampicillin in human serum and evaluate its clinical application in ICU patients. Methods: Sample cleanup included a protein precipitation protocol, followed by chromatographic separation on a C18 reverse-phase HPLC column within 12.5 minutes using gradient elution of the mobile phase. The assay was validated according to the German Society of Toxicology and Forensic Chemistry criteria. Clinical applications involved the retrospective analysis of TDM data from ICU patients receiving continuous infusion of ampicillin/sulbactam, including the attainment of target ranges and individual predicted and observed pharmacokinetics. Results: The method was robust, with linear relations between the peak area responses and drug concentrations in the range of 2-128 mg/L. The coefficient of variation for precision and the bias for accuracy (both interday and intraday) were less than 10%. Clinical application revealed variable pharmacokinetics of ampicillin in ICU patients (clearance of 0.5-31.2 L/h). TDM-guided dose adjustments achieved good therapeutic drug exposure, with 92.9% of the samples being within the optimal (16-32 mg/L) or quasioptimal (8-48 mg/L) range. Conclusions: This method provides a practical solution for the routine TDM of ampicillin, facilitating individualized dosing strategies to ensure adequate therapeutic drug exposure. Given its simplicity, cost-effectiveness, and clinical relevance, HPLC-ultraviolet spectrometry holds promise for broad implementation in hospital pharmacies and clinical laboratories.
Application of isoindole fluorophore formation for determination of linagliptin in the sole and co-formulated tablets: Application for plasma assay and content uniformity testing

Ahmed A Abu-Hassan,Mohamed A El Hamd,Mahmoud H El-Maghrabey,Wael A Mahdi,Sultan Alshehri,Bassam Shaaban Mohammed

DOI: https://doi.org/10.1016/j.saa.2023.122390

2023-04-15

Abstract:Linagliptin is a new medicament belonging to dipeptidyl peptidase-4 enzyme inhibitors group. The mentioned medication is used to cure type 2 diabetes and is taken orally as a monotherapy or in a co-formulation with metformin. or empagliflozin. Herein, a novel, straightforward, and cost-effective method for linagliptin assay was developed with a workable use of an isoindole derivative. The primary amine moiety present in linagliptin enables its condensation with o-phthalaldehyde to form a fluorescent product in the presence of a sulfhydryl group-containing compound (2-mercaptoethanol) 0.01 % V/V. The isoindole fluorophore yield was monitored at (λexcitation 337.8 nm, λemission 434.3 nm) and all experimental variables were meticulously checked and adjusted. Fluorescence intensity versus linagliptin concentration was plotted to construct the calibration graph, and excellent linearity was achieved at values between 50 and 2000 ng/mL. The validity of the method was verified through a rigorous examination of the ICH guidelines. The method application was successful for linagliptin in different dosage forms, content uniformity study, and monitoring in spiked plasma. The devised technique was demonstrated to be a promising, easy, and quick alternate method for linagliptin assayin clinical study and quality control.
A Low-Volume LC/MS Method for Highly Sensitive Monitoring of Phenoxymethylpenicillin, Benzylpenicillin, and Probenecid in Human Serum

Alaa Riezk,Richard C Wilson,Anthony E G Cass,Alison Holmes,Timothy M Rawson

DOI: https://doi.org/10.1039/d3ay01816d

IF: 3.1

2024-01-04

Analytical Methods

Abstract:Background: The optimization of antimicrobial dosing plays a crucial role in improving the likelihood of achieving therapeutic success while reducing the risks associated with toxicity and antimicrobial resistance. Probenecid has shown significant potential in enhancing the serum exposure of phenoxymethylpenicillin, thereby allowing for lower doses of phenoxymethylpenicillin to achieve similar pharmacokinetic/pharmacodynamic (PK/PD) targets. We developed a triple quadrupole liquid chromatography mass spectrometry (TQ LC/MS) analysis of, phenoxymethylpenicillin, benzylpenicillin and probenecid using benzylpenicillin-d7 and Probenecid-d14 as IS in single low-volumes of human serum, with improved limit of quantification to support therapeutic drug monitoring. Methods: Sample clean-up was performed by protein precipitation using acetonitrile. Reverse phase chromatography was performed using TQ LC/MS. The mobile phase consisted of 55% methanol in water + 0.1% formic acid, with a flow rate of 0.4 ml/min. Antibiotic stability was assessed at different temperatures. Results: Chromatographic separation was achieved within 2 minutes, allowing simultaneous measurement of phenoxymethylpenicillin, benzylpenicillin and probenecid in a single 15 μl blood sample. Validation indicated linearity over the range 0.0015-10 mg/L, with accuracy of 96-102% and a LLOQ of 0.01mg/L. All drugs demonstrated good stability under different storage conditions. Conclusion: The developed method is simple, rapid, accurate and clinically applicable for the quantification of phenoxymethylpenicillin, benzylpenicillin and probenecid in tandem.

spectroscopy,chemistry, analytical,food science & technology
Developing an analytical method for quantification of trientine based on modified silver nanoparticles

Mahsa Khodadadi,Ali Shayanfar

DOI: https://doi.org/10.1186/s13065-023-01068-0

2023-11-09

BMC Chemistry

Abstract:Trientine or (N,N ́-bis(2-aminoethyl)-1,2-ethanediamine (TETA) is a copper chelator and used in Wilson's disease, is aliphatic amine that does not have UV absorbing groups. In this study, the modified silver nanoparticles (AgNPs) by sodium lauryl sulfate have been used to develop an analytical method for quantification of TETA. Different concentrations of TETA were added into a particular concentration of AgNPs and absorbance of each sample was measured at 397 nm under the optimal conditions which include pH, time, salt and AgNPs volume. It was optimized by a design of experiments using response surface methodology. Then, the calibration curve was obtained based on the concentrations of TETA solution versus decrease in the absorbance of AgNPs. Selectivity of the developed method was performed in plasma and presence of common cations i.e. copper, zinc and ferrous. Under optimum conditions, linear range of this method was between 10 and 40 ng.mL − 1 with correlation coefficient (R 2 ) of 0.996 with limit of detection and quantification of 3 ng.mL − 1 and 10 ng.mL − 1 , respectively. Selectivity of established method in presence of cations eliminated by diluting because of high sensitivity of the established analytical techniques based on AgNPs. This method is suitable and low costing for quantification of TETA and does not require high equipment.

chemistry, multidisciplinary
A highly sensitive pre-column derivatization method for fluorescence detection of tobramycin using 2-naphthalenesulfonyl chloride as a derivatizing agent

Mokhtar M. Mabrouk,Suzan M. Soliman,Heba M. El-Agizy,Fotouh R. Mansour

DOI: https://doi.org/10.1007/s43938-022-00014-1

2022-12-27

Discover Chemical Engineering

Abstract:A new, simple, rapid and highly sensitive high performance liquid chromatographic method was developed for the determination of tobramycin (TOB) in ophthalmic solutions. The developed method was based on derivatizing this non-chromophoric drug with 2-naphthalenesulfonyl chloride (NSCl), at 80 oC for 40 min, and measuring the fluorescent product. Elution from the column was isocratic, using a mobile phase consisting of acetonitrile –1% phosphoric acid in water, (90:10, v/v ), with a flow rate of 2 mL/min, at 40 oC. Determination was developed using fluorescence detection at an excitation wavelength of 300 nm and an emission wavelength of 380 nm. The chromatographic separation was achieved on Knauer-Eurospher 100–5 C18 silica column (300 mm × 4 mm i.d, 5 μm). Different approaches were used to optimize the conditions of the method and to reach the maximum yield. The linear regression data for the calibration plot showed acceptable correlation coefficient (r 2 = 0.9998) at the concentration ranges of 2.5–1000 ng/mL for TOB. The method was successfully validated according to the guidelines of the International Council on Harmonization, and was found suitable for pharmaceutical applications. The method was new, simple and precise for analysis of TOB and applicable for routine analysis in quality control laboratories.

English Else
A rapid HPLC–DAD method for quantification of amikacin in pharmaceuticals and biological samples using pre-column derivatization with Hantzsch reagent

Madan Lal Maheshwari,Najma Memon,Ayaz Ali Memon,Muhammad Yar Khuhawar,Abdul Hakeem Memon

DOI: https://doi.org/10.1007/s13738-020-02046-2

2020-09-08

Journal of the Iranian Chemical Society

Abstract:Amikacin (AMK) is an important member of aminoglycoside class, and its determination has therapeutic importance due to its matchless potency against gram –ve pathogens. Due to narrow therapeutic window, its monitoring in clinical samples is inevitable. Direct determination of AMK using HPLC with UV–visible detection is not possible because of its limited absorbance. Herein, Hantzsch reagent (mixture of acetylacetone, formaldehyde and acetate buffer) was used as pre-column derivatization for AMK. UV–visible detection was performed at 340 nm. Separation and identification of derivatized drug (amikacin) were carried out using C-18 column Kromasil 100 (15 cm × 0.46 mm, 5 μm) with isocratic mobile phase elution of pH 5 (acetate buffer 0.01 M):acetonitrile (30:70 v/v) with flow rate of 1 ml/min. The procedure was able to resolve AMK from endogenous compounds and from cephalosporin drug (most prescribed combination) with run time of 10 min. Under optimized conditions; calibration curve was linear in the range 0.10–25.0 µg/mL with LOD and LOQ values of 0.024 and 0.071 µg/mL. Method was also validated for reproducibility, ruggedness and accuracy. The procedure was found sensitive, robust and precise for the comprehensive analysis (qualitative and quantitative) that was applied for determination of AMK in pharmaceuticals, urine and blood samples.

chemistry, multidisciplinary
A quantitative method for the analysis of total and unbound concentrations of amoxicillin, ampicillin, ceftazidime, ceftriaxone, ertapenem, fosfomycin and penicillin G in human plasma with liquid chromatography-tandem mass spectrometry assay

Marlotte A A van der Veer,Marloes van der Meer-Vos,Timo R de Haan,Linda G W Franken,Yuma A Bijleveld,Ron A A Mathôt

DOI: https://doi.org/10.1002/bmc.5956

2024-08-01

Abstract:Monitoring antibiotic plasma levels is critical in populations with altered pharmacokinetics, such as critically ill patients in neonatal or adult intensive care units. This study aimed to develop and validate a rapid, reproducible and sensitive liquid chromatography-tandem mass spectrometry assay (LC-MS/MS) for measuring total and unbound concentrations of amoxicillin, ampicillin, ceftazidime, ceftriaxone, ertapenem, fosfomycin and penicillin G in human plasma. The method required 20 and 250 μl sample volumes for measuring total and unbound concentrations, respectively. Sample preparation involved protein precipitation and the addition of an internal standard. Ultrafiltration separated unbound drugs. Method validation covered selectivity, carryover, linearity, accuracy, precision, dilution effects, matrix effects and stability. The LC-MS/MS was performed within a run time of 7.5 min. Calibration curves were linear for ceftazidime and ertapenem (ranges 0.1-50 and 0.05-100 mg/l, respectively) and quadratic for other analytes (0.1-50 mg/l, except for ampicillin: 0.1-20 mg/l; R2 > 0.990). Accuracy was within ±15% of the nominal concentration, and precision did not exceed ±15% (relative standard deviation). Samples showed no significant degradation at the tested temperatures and time points. Clinical applicability was demonstrated in a critically ill neonate. This method with minimal sample volume and short analysis time enables the measurement of total and unbound concentrations of selected antibiotics, and is suitable for routine clinical care and studies.
A liquid chromatography-tandem mass spectrometry method for the determination of amikacin in human serum and its clinical application

Xiaolin PENG,Yaxin FAN,Liang ZHANG,Yi LI,Jicheng YU,Beining GUO,Daijie CHEN,Jing ZHANG,Xiaojie WU

2017-01-01

Abstract:AIM To establish a rapid,accurate liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of amikacin in human serum and apply this method to analyze the clinical samples.METHODS Serum samples were spiked with kanamycin (internal standard,IS),pretreated by protein precipitation with 0.1％ formic acid in methanol-acetonitrile (2∶1) and then diluted for injection.The compounds were separated by Atlantis(R) Hilic Silica column (50 mm × 2.1 mm,3.0 μm).The detection was performed in selected reaction monitoring mode at ion transition of m/z 586.3→163.0 for amikacin and m/z 485.2→163.0 for IS.After methodology validation,this method was applied for the clinical analysis of amikacin in serum specimens from patients.RESULTS The calibration curve was linear over the range from 0.50 mg · L-1 to 100.00 mg ·L-1,with a correlation coefficient (R2) of 0.993 8.The intra-and inter-batch precision (coefficient of variation)was less than 15.0％,the accuracy ranged from 92.6％ to 105.9％.The internal standard normalized matrix effect ranged from 91.2％ to 101.2％,coefficient of variation was less than 15.0％.The values of extraction recovery were from 92.6％ to 105.9％ for amikacin and 78.1％ for IS.The samples were stored stably as follows:56 days at 4℃,86 days at-70℃,21 days at 35℃ and room temperature.Thirty-four trough concentration serum samples were collected from 19 patients,the concentrations of 16 samples were under lower limit of quantification,while the others were between 0.52 mg· L-1 and 19.12 mg · L-1.CONCLUSION The method is simple,accurate and suitable for the determination of amikacin in human serum.A significant difference among concentrations of trough samples suggests that it's necessary to conduct therapeutic drug monitoring when using amikacin in the clinics.

Acoustic pattern recognition and orientation in orthopteran insects: parallel or serial processing?

Determination of Diphenytriazol (DL111-IT) in Rabbit Plasma by High-Performance Liquid Chromatography with Fluorescence Detection

Quantification of Teicoplanin in Human Plasma by Liquid Chromatography with Ultraviolet Detection

Design and strategy for spectrofluorimetric determination of tranexamic acid in its authentic form and pharmaceutical preparations: application to spiked human plasma

Analysis using fluorescence polarization immunoassay for unbound teicoplanin concentration in serum

Simultaneous quantification of linezolid, tinidazole, norfloxacin, moxifloxacin, levofloxacin, and gatifloxacin in human plasma for therapeutic drug monitoring and pharmacokinetic studies in human volunteers

Development and validation of a sensitive liquid chromatography-tandem mass spectrometry method for the determination of naringin and its metabolite, naringenin, in human plasma.

Spectrofluorimetric determination of Alogliptin benzoate through condensation with ninhydrin and phenylacetaldehyde: application to dosage form and rat plasma

Application of the green analytical procedure index to the simultaneous analysis of co-formulated tinidazole and ciprofloxacin in pure form, tablet dosage form, and human plasma using an environmentally friendly micellar high-performance thin-layer chromatographic technology

An Analytical Method Built for Irinotecan and Its Active Metabolite SN-38 in Human Plasma Using HPLC-FLD

Utility of Experimental Design in Pre-Column Derivatization for the Analysis of Tobramycin by HPLC—Fluorescence Detection: Application to Ophthalmic Solution and Human Plasma

A probe of new molecularly imprinted solid-phase extraction coupled with HPLC-DAD and atomic absorption spectrophotometry for quantification of tetracycline HCl, metronidazole and bismuth subcitrate in combination with their official impurities: Application in dosage form and human plasma

Mechanisms of inactivation of deoxyribonucleic acids by heat.

Development and Validation of a High-Performance Liquid Chromatography-Ultraviolet Spectrometry Method for Ampicillin and its Application in Routine Therapeutic Drug Monitoring of Intensive Care Patients

Application of isoindole fluorophore formation for determination of linagliptin in the sole and co-formulated tablets: Application for plasma assay and content uniformity testing

A Low-Volume LC/MS Method for Highly Sensitive Monitoring of Phenoxymethylpenicillin, Benzylpenicillin, and Probenecid in Human Serum

Developing an analytical method for quantification of trientine based on modified silver nanoparticles

A highly sensitive pre-column derivatization method for fluorescence detection of tobramycin using 2-naphthalenesulfonyl chloride as a derivatizing agent

A rapid HPLC–DAD method for quantification of amikacin in pharmaceuticals and biological samples using pre-column derivatization with Hantzsch reagent

A quantitative method for the analysis of total and unbound concentrations of amoxicillin, ampicillin, ceftazidime, ceftriaxone, ertapenem, fosfomycin and penicillin G in human plasma with liquid chromatography-tandem mass spectrometry assay

A liquid chromatography-tandem mass spectrometry method for the determination of amikacin in human serum and its clinical application